Pirfenidone: A Potential New Therapy for Restrictive Allograft Syndrome?

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|13|11|3035-3040

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.13, Iss.11, 2013-11, pp. : 3035-3040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Concomitant Therapy with Pirfenidone and Nintedanib in Idiopathic Pulmonary Fibrosis: A Case Report

By  

Respiration, Vol. 91, Iss. 4, 2016-04 ,pp. : 327-332

Karger

Access to resources Recommend Favorite

Use of IVIg to identify potential miRNA targets for allograft rejection and GvHD therapy

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 6, 2015-06 ,pp. : 543-546

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypochondriasis Associated with Organic Brain Syndrome: A New Approach to Therapy

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 24, Iss. 9, 1976-09 ,pp. : 430-431

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination pirfenidone and inhaled N‐acetylcysteine therapy for IPF: Does it take these two to tango?

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2015-04 ,pp. : 359-360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pirfenidone and inhaled NAC for IPF

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2015-04 ,pp. : 445-452

John Wiley & Sons Inc

Access to resources Recommend Favorite